Find out more about Hendrik Falk's experience
Hendrik Falk's highlights
FEATURED Conference Proceedings
First-in-class KAT6A/KAT6B inhibitor CTx-648 (PF-9363) demonstrates potent anti-tumor activity in ER plus breast cancer with KAT6A dysregulation.
Read moreHendrik Falk's selected work
Temporal Analysis of Brd4 Displacement in the Control of B Cell Survival, Proliferation, a..
Journal article
Discovery of Acylsulfonohydrazide-Derived Inhibitors of the Lysine Acetyltransferase, KAT6..
Journal article
HBO1 is required for the maintenance of leukaemia stem cells
Journal article
Development of small molecule STING agonists that can evoke host anti-cancer immune defenc..
Conference Proceedings
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma
Journal article
Discovery of Benzoylsulfonohydrazides as Potent Inhibitors of the Histone Acetyltransferas..
Journal article
Hendrik Falk's selected work
Scholarly Works
Displaying the 10 most recent scholarly works from 21 for Hendrik Falk.
Credentials
Positions
Honorary
Medical Biology (w.e.h.i.)
Member
European Association for Cancer Research (EACR)
Member
Society for Laboratory Automation and Screening
Education
Dr. rer. nat. in Biochemistry
Free University of Berlin